VRANCKX, Pascal

Full Name
VRANCKX, Pascal
Email
pascal.vranckx@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  2016

Results 1-8 of 8 (Search time: 0.005 seconds).

Issue DateTitleContributor(s)TypeCat.
12016Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarctionPilgrim, Thomas; VRANCKX, Pascal; Valgimigli, Marco; Stefanini, Giulio G.; Piccolo, Raffaele; Rat, Julie; Rothenbuehler, Martina; Stortecky, Stefan; Raeber, Lorenz; Bloechlinger, Stefan; Hunziker, Lukas; Silber, Sigmund; Jueni, Peter; Serruys, Patrick W.; Windecker, StephanJournal ContributionA1
22016Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trialGargiulo, Giuseppe; Costa, Francesco; Ariotti, Sara; Biscaglia, Simone; Campo, Gianluca; Esposito, Giovanni; Leonardi, Sergio; VRANCKX, Pascal; Windecker, Stephan; Valgimigli, MarcoJournal ContributionA1
32016A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?Gargiulo, Giuseppe; Windecker, Stephan; VRANCKX, Pascal; Gibson, Charles Michael; Mehran, Roxana; Valgimigli, MarcoJournal ContributionA1
42016Standardization of Fractional Flow Reserve MeasurementsToth, Gabor G.; Johnson, Nils P.; Jeremias, Allen; Pellicano, Mariano; VRANCKX, Pascal; Fearon, William F.; Barbato, Emanuele; Kern, Morton J.; Pijls, Nico H. J.; De Bruyne, BernardJournal ContributionA1
52016Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER TrialVRANCKX, Pascal; White, Harvey D.; Huang, Zhen; Mahaffey, Kenneth W.; Armstrong, Paul W.; Van de Werf, Frans; Moliterno, David J.; Wallentin, Lars; Held, Claes; Aylward, Philip E.; Cornel, Jan H.; Bode, Christoph; Huber, Kurt; Nicolau, Jose C.; Ruzyllo, Witold; Harrington, Robert A.; Tricoci, PierluigiJournal ContributionA1
62016Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting scent implantation: rationale and design of the GLOBAL LEADERS trialVRANCKX, Pascal; Valgimigli, Marco; Windecker, Stephan; Steg, Philippe Gabriel; Hamm, Christian; Juni, Peter; Garcia-Garcia, Hector M.; van Es, Gerrit Anne; Serruys, Patrick W.Journal ContributionA1
72016Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy durationCosta, Francesco; Adamo, Marianna; Ariotti, Sara; Ferrante, Giuseppe; Navarese, Eliano Pio; Leonardi, Sergio; Garcia-Garcia, Hector; VRANCKX, Pascal; Valgimigli, MarcoJournal ContributionA1
82016Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?Ariotti, Sara; Adamo, Marianna; Costa, Francesco; Patialiakas, Athanasios; Briguori, Carlo; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; VRANCKX, Pascal; Valgimigli, MarcoJournal ContributionA1